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utations in the DSL (Delta, Serrate, Lag2) Notch
(N) ligand Delta-like (Dll) 3 cause skeletal ab-
normalities in spondylocostal dysostosis, which
is consistent with a critical role for N signaling during
somitogenesis. Understanding how Dll3 functions is com-
plicated by reports that DSL ligands both activate and in-
hibit N signaling. In contrast to other DSL ligands, we
show that Dll3 does not activate N signaling in multiple
assays. Consistent with these ﬁndings, Dll3 does not bind
to cells expressing any of the four N receptors, and N1
M
 
does not bind Dll3-expressing cells. However, in a cell-
autonomous manner, Dll3 suppressed N signaling, as
was found for other DSL ligands. Therefore, Dll3 functions
not as an activator as previously reported but rather as a
dedicated inhibitor of N signaling. As an N antagonist,
Dll3 promoted 
 
Xenopus laevis 
 
neurogenesis and inhibited
glial differentiation of mouse neural progenitors. Finally,
together with the modulator lunatic fringe, Dll3 altered
N signaling levels that were induced by other DSL ligands.
 
Introduction
 
Functional studies of Notch (N) pathway genes have impli-
cated this signaling system in the development of almost all
structures within the vertebrate body plan. In particular, losses
in core components (N1, Delta-like [Dll] 1, Dll3, presenilin-1,
kuzbanian, and RBP-J) as well as in targets and modulators
(Hes7, Mesp2, and lunatic fringe [LFng]) of the N signaling
pathway all perturb the formation and patterning of somites
(for review see Weinmaster and Kintner, 2003; Giudicelli and
Lewis, 2004). Correct segmentation and patterning of somites
is essential for proper axial skeletal formation, and mutations in
Dll3 produce vertebral segmentation and rib defects in both
spondylocostal dysostosis patients (Bulman et al., 2000; Turn-
penny et al., 2003) and the pudgy mouse (Kusumi et al., 1998,
2004). Although it is clear that N signaling regulates somitoge-
nesis, it is not clear which DSL (Delta, Serrate, Lag2)
 
 
 
ligand
activates N during this process. Of the DSL ligands that are ex-
pressed in the presomitic mesoderm (PSM), only Dll3 and Dll1
mutant mice display somitic defects; however, Dll3 and Dll1
mutant phenotypes differ with respect to the expression of
somite markers and genes whose rhythmic expression is regu-
lated by N (Dunwoodie et al., 2002; Zhang et al., 2002;
Kusumi et al., 2004). Although it is difficult to discern from
phenotypes and gene expression patterns alone, these different
mutant phenotypes may reflect distinct roles for Dll1 and Dll3
in regulating N signaling during somitogenesis. In fact, the
somite defects that are seen in Dll3 mutant mice are more simi-
lar to those reported in modulators of N signaling (LFng, Hes7,
or Mesp2) rather than in mice lacking the well-characterized
activating N ligand Dll1.
Activation of N signaling relies on contact between cells
to allow the transmembrane DSL ligand on one cell to bind its
receptor on an apposing cell. During its trafficking to the cell
surface, N is constitutively processed by a furin-type protease
producing a heterodimer that is composed of noncovalently as-
sociated extracellular and transmembrane subunits (Logeat et
al., 1998). In response to ligand binding, the N heterodimer dis-
sociates to release the extracellular domain from its membrane-
bound portion (Sanchez-Irizarry et al., 2004; Weng et al.,
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2004). Removal of the extracellular domain is necessary for re-
ceptor activation that is mediated by proteolysis, first by a dis-
integrin and metalloprotease cleavage within the extracellular
domain followed by a presenilin/
 
 
 
-secretase intramembrane
cleavage (for review see Mumm and Kopan, 2000; Weinmas-
ter, 2000). These ligand-dependent cleavages allow the biolog-
ically active N intracellular domain (NICD) to be released from
the plasma membrane and move to the nucleus, where it di-
rectly binds to the transcription factor CSL (CBF1, SuH,
LAG-1). Through interactions with NICD, CSL is converted
from a repressor into an activator of transcription to regulate N
target gene expression. In addition to this well-characterized
role for activation of N signaling through cell–cell interactions,
DSL ligands have also been reported to cell autonomously an-
tagonize N signaling in both vertebrate and invertebrate systems
(Heitzler and Simpson, 1993; Henrique et al., 1997; Jacobsen et
al., 1998; de Celis and Bray, 2000; Sakamoto et al., 2002; Itoh
et al., 2003).
In this study, we show that Dll3 does not induce N signal-
ing in multiple assay systems that measure the activation of N
in response to DSL ligands. Our findings that Dll3 does not ac-
tivate any of the known mammalian N receptors is in conflict
with a previous study that found Dll3 activates N signaling
(Dunwoodie et al., 1997). We find that, unlike other activating
DSL ligands, Dll3 does not bind to cells expressing N recep-
tors, and, conversely, N1 does not bind to Dll3-expressing
cells. Although Dll3 did not bind or activate N when presented
in trans, it cell autonomously inhibited N signaling that was in-
duced by other DSL ligands in CSL gene reporter, 
 
Xenopus
laevis 
 
primary neurogenesis, and mouse embryonic neural pro-
genitor differentiation assays. Dll3 also cell autonomously at-
tenuated the enhancement of Dll1-induced N signaling that was
mediated by the modulator LFng, and Dll3 inhibition was re-
versed by LFng. This demonstrated that, together, Dll3 and
LFng can modulate the levels of N signaling. Altogether, our
analyses indicate that unlike other DSL ligands that either acti-
vate or inhibit N signaling depending on the cellular context,
the primary function of Dll3 is to inhibit ligand-induced N sig-
naling and, thereby, serve to attenuate the level of N signaling
that is required to direct specific cell fates.
 
Results
 
Dll3 does not activate N signaling
 
We isolated cDNA clones encoding rat Dll3 (rDll3) and engi-
neered a full-length COOH terminally HA-tagged rDll3 for ex-
pression in L cells. An analysis of biotinylated cell surface pro-
teins indicated that rDll3 and Dll1 are expressed to similar
levels on the surface of expressing cells (Fig. 1 A). To determine
which N receptors are activated by rDll3, we used a coculture
assay to measure activation of the N downstream effector CSL
(Nofziger et al., 1999; Hicks et al., 2000, 2002; Bush et al.,
2001). In brief, NIH 3T3 cells were cotransfected with each of
the known N receptors (N1–4) and with a CSL reporter con-
struct containing multiple CSL-binding sites that were up-
stream of a luciferase gene (Hsieh et al., 1996). After coculture
with Dll1, Jagged-1 (J1), rDll3, or parental L cell lines, quanti-
tation of luciferase activity indicated the level of ligand-
induced CSL-dependent N signaling. Dll1 and J1 activated CSL
in N1-, N2- (Fig. 1 B), N3-, and N4-expressing cells (not de-
picted). However, rDll3 did not activate signaling from any of
the four known N receptors (Fig. 1 B and not depicted) despite
equivalent cell surface levels. This lack of activity was not lim-
ited to the HA-tagged rDll3 cDNA clone because cells express-
ing untagged mouse Dll3 (mDll3; Dunwoodie et al., 1997)
were also inactive in this assay (Fig. 1 B). Moreover, Dll3 cells
did not activate the CSL reporter that was expressed in C2C12
myoblasts, COS, or N2A neuroblastoma cells (unpublished
data), indicating that Dll3 cannot activate N signaling in multi-
ple cell types.
Another measure of ligand-induced N signaling is the
inhibition of myogenic differentiation of C2C12 myoblasts
stably expressing N1 after coculture with cells expressing DSL
ligands. In this assay, suppressed expression of the muscle
structural gene myosin light chain 2 (MLC2) provides a read-
out of N signaling that is induced by ligands (Fig. 1 C;
Nofziger et al., 1999; Bush et al., 2001). In contrast to Dll1 and
J1 cells that strongly suppress the expression of MLC2, neither
Figure 1. Dll3 does not activate N signaling in trans. (A) Cell surface
expression of HA-tagged Dll1, Dll3, and Dll1   Dll3 L cell lines was de-
termined by biotinylation, streptavidin (SAV) pull-down, and blotting with
anti-HA mAb (12CA5). (B) NIH 3T3 cells transfected with N and CSL re-
porter were cocultured with J1, Dll1, Dll3, mDll3, or parental (L) cell lines
and were assayed for luciferase activity. Error bars reflect the SD of the
mean from three experiments. RLU, relative luciferase units. (C) Parental
C2C12 and cell lines expressing N1 were cocultured with L, J1, Dll1, or
Dll3 cells, and myogenesis was monitored by myosin light chain 2 (MLC2)
mRNA expression. Loading and transfer of RNA was monitored by methyl-
ene blue staining of 18S rRNA. (D) NIH 3T3 cells transfected with N1,
CSL reporter, and control or LFng were cocultured with Dll1, J1, rDll3,
mDll3, or L cells and were assayed for luciferase activity (n = 3). (E) Paren-
tal L, Dll1, or Dll1   Dll3 cells were cocultured with NIH 3T3 cells trans-
fected with CSL reporter and N or vector. There was no statistically signifi-
cant difference between Dll1 and Dll1   Dll3 (n = 3). 
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N1 nor N2 C2C12 myoblasts showed diminished MLC2 ex-
pression relative to parental L cells when cocultured with Dll3
cells (Fig. 1 C and not depicted). Therefore, Dll3 cells do not
suppress C2C12 myogenic differentiation, which is consistent
with our findings that Dll3 does not activate an N-responsive
reporter construct (Fig. 1 B), providing an additional measure
of Dll3’s inability to activate N signaling.
 
LFng does not enable Dll3 to activate 
N1 signaling
 
We have previously reported that the glycosyltransferase LFng
enhances Dll1-induced N signaling by using CSL reporter as-
says (Hicks et al., 2000; Yang et al., 2004). To determine
whether LFng modification of N enables Dll3 to function as an
activating ligand, NIH 3T3 cells were cotransfected with either
alkaline phosphatase–tagged LFng or secreted alkaline phos-
phatase with N1 and a CSL reporter. Although LFng enhanced
Dll1 activation of N1 and suppressed J1 activation of N1 as
previously reported, neither rDll3 nor mDll3 activated N1 in
the presence or absence of LFng (Fig. 1 D). Moreover, the
other fringe family members radical and manic did not facili-
tate Dll3 activation of N1 or N2 (unpublished data). Together,
these data suggest that fringe glycosylation of N does not en-
able Dll3 to function as an activating ligand.
 
Dll3 coexpressed with Dll1 does not 
perturb Dll1-induced N signaling
 
Given the inability of Dll3 to activate N signaling and the fact
that Dll1 and Dll3 are coexpressed during development (Dun-
woodie et al., 2002; Zhang et al., 2002; Takahashi et al., 2003),
we asked whether Dll3 could alter Dll1-induced N signaling.
Cells stably expressing both Dll1
 
 
 
and
 
 
 
Dll3 were derived from
the Dll1 line and were tested for CSL activation by either N1 or
N2. Despite high levels of Dll3 expression on the surface of
Dll1 
 
 
 
 Dll3 cells relative to Dll1 cells (Fig. 1 A), they also ac-
tivated the CSL reporter as found for Dll1 cells (Fig. 1 E), indi-
cating that Dll3 does not antagonize Dll1-induced signaling.
 
Dll3 does not bind to N1 in trans
 
Because neither rDll3- nor mDll3-expressing cells activated N
in either CSL reporter or myogenesis coculture assays, we de-
termined whether Dll3 binds to N1. Based on the structure of a
soluble D1Fc fusion protein that binds N1 and activates signal-
ing, a Dll3Fc protein was generated by fusing the extracellular
domain of Dll3 to Fc to allow clustering by anti-Fc antibodies,
which is required for binding and activation (Hicks et al., 2000,
2002; Yang et al., 2004). When comparable amounts of Dll3Fc
and D1Fc (Fig. 2 A) were assayed for binding to N1 cells, only
DlFc binding was detected (Fig. 2 B). Furthermore, although a
low level of D1Fc binding was detected with vector-transfected
cells, which is presumably a result of endogenous N, Dll3Fc
did not bind to either vector or N1-transfected 293T cells (Fig.
2 B). Using fluorescent microscopy to monitor binding, Dll3Fc
did not bind to any of the known N receptors even though
D1Fc binding was readily imaged (not depicted). Moreover,
the coexpression of LFng with N1 or N2 did not enable Dll3Fc
binding (not depicted).
Although in agreement with our coculture data, the lack of
detected Dll3Fc binding could result from low expression or
misfolding of soluble Dll3Fc. Therefore, we determined whether
a soluble N1Fc could bind Dll3-expressing cells. Although
N1Fc binds to cells expressing either Dll1 (Fig. 2 C) or J1 (not
depicted), N1Fc did not bind to Dll3 cells (Fig. 2 C). The lack of
detected Dll3–N1 interactions in these binding assays is consis-
tent with the inability of Dll3 L cells to activate N signaling in
CSL reporter and myogenesis assays (Fig. 1, B and C).
When compared with other Dll ligands, it is obvious that
the Dll3 DSL domain has not been conserved (Fig. 2 D). Given
that the DSL domain is required for ligand binding and signal-
ing (Henderson et al., 1997; Shimizu et al., 1999), our data sug-
gested that the divergent Dll3 DSL module does not support
binding to N when presented either on the surface of interact-
ing cells or as a soluble protein. Because D1Fc binds to
N-expressing cells and Dll1 activates N signaling, we reasoned
that replacement of the Dll3 NH
 
2
 
-terminal and DSL domains
(NT-DSL) with those of Dll1 (D1
 
NT
 
) would allow Dll3 to inter-
act with N. To test this idea, we replaced the Dll3 NT-DSL in
Dll3Fc with D1
 
NT
 
 to produce a soluble D1
 
NT
 
D3Fc. Although
comparable amounts of D1
 
NT
 
D3Fc, D1Fc, and Dll3Fc were
used (Fig. 2 A), we were unable to detect the binding of
D1
 
NT
 
D3Fc to N1-expressing cells. Moreover, when the D3
 
NT
 
sequences were replaced with D1
 
NT
 
 in the full-length Dll3 HA-
tagged protein (D1
 
NT
 
D3), cells expressing D1
 
NT
 
D3 did not
bind N1Fc (Fig. 2 C). Together, our findings suggest that the
Figure 2. Dll3 does not bind to N. (A) Western Blot (WB) analysis using
anti-Fc quantitated Dll3Fc, D1Fc, and D1
NTD3Fc for binding assays in B.
Numbers represent the dilution of condition media used in the binding
assays. (B) 293T cells transfected with vector or N1 were assayed for
binding of Fc, Dll3Fc, D1
NTD3Fc, and D1Fc by flow cytometry. Fold bind-
ing over Fc control is plotted against serial dilutions. (C) Binding of N1Fc
to 293T cells transfected with vector or HA-tagged Dll1, Dll3, or D1
NTD3
is shown as fold binding over vector control (n   3). Error bars represent
SD. (D) Alignment of the DSL domains of rat and mDll3 with other Dll fam-
ily members identifies Dll3 as highly divergent. Amino acid sequences
conserved in Dll3 are red, whereas amino acid sequences conserved
amongst the other Dll-related proteins are blue. 
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divergent Dll3 DSL domain is not solely responsible for the lack
of detected trans interactions for Dll3 and N receptor proteins.
 
Dll3 inhibits N signaling cell 
autonomously
 
Because Dll3 did not bind or activate any of the known N recep-
tors when presented in trans, we determined whether Dll3 inhib-
its N signaling when expressed with N in the same cell (cis or
cell autonomously), as previously reported for other DSL family
proteins (Henrique et al., 1997; Sakamoto et al., 2002; Itoh et al.,
2003). To determine whether Dll3 could cell autonomously in-
hibit N signaling that is induced by other DSL ligands, NIH 3T3
cells transiently expressing either N1 or N2, CSL reporter, and
either vector, Dll1, or Dll3 plasmids were cocultured with Dll1,
J1, or L cells. In these assays, CSL reporter activity was de-
creased 
 
 
 
60% when either Dll1 or Dll3 were coexpressed with
either N1 or N2 (Fig. 3 A). Serrate has also been reported to cell
autonomously inhibit N (de Celis and Bray, 2000; Kiyota and
Kinoshita, 2004), and J1 that was coexpressed with N1 or N2
also suppressed CSL activation (unpublished data). Therefore,
unlike other DSL ligands that both activate and inhibit N signal-
ing, Dll3 cannot activate signaling in trans but effectively inhib-
its ligand-induced N signaling when coexpressed with N.
 
Dll3 cell-autonomous expression does 
not decrease cell surface N1
 
To ensure that the loss in N signaling, which is detected when
either Dll3 or Dll1 were coexpressed with N, was not caused by
decreased N1 cell surface expression, N1 cell surface levels in
the presence of either Dll1 or Dll3 were determined. Biotinyla-
tion of cell surface proteins indicated that the coexpression of
either Dll1 or Dll3 with N1 did not decrease the amount of N1
that was detected in whole cell lysates (WCLs; Fig. 3) or the
level of N1 that was detected at the cell surface (streptavidin
[SAV]; Fig. 3 C). These findings are in agreement with a study
on N cell surface expression in cells coexpressing chick Delta1
and mouse N1 (Sakamoto et al., 2002). To more accurately
quantitate the level of N1 cell surface expression, cells coex-
pressing either Dll1 or Dll3 with an NH
 
2
 
-terminal HA-tagged
N1 (HA-N1) were stained with AlexaFluor488-conjugated HA
antibody and were analyzed by flow cytometry. In agreement
with our biotinylation data, the expression of Dll3 with N1 did
not significantly alter cell surface N1 (Fig. 3 D), suggesting
that losses in cell surface N1 cannot account for losses in sig-
naling (Fig. 3 A). Furthermore, biotinylation analysis of Dll1
and Dll3 indicate that neither Dll1 nor Dll3 surface expression
was altered when coexpressed with N1 (Fig. 3 E). This sug-
gests that the overexpression of ligand and receptor in the same
cell does not alter trafficking to the cell surface.
 
Dll3 directly interacts with N1 in 
coexpressing cells
 
Our binding studies did not detect interactions between Dll3
and N1 (Fig. 2, B and C); however, these experiments mea-
sured trans interactions rather than interactions between Dll3
and N1 within the same cell. Therefore, to detect cis interac-
tions between Dll3 and N1, we determined whether Dll3
coimmunoprecipitated with N1. 293T cell lysates from cells
coexpressing N1 and either vector, HA-tagged Dll3, or Dll1
were immunoprecipitated with N1 antibodies and immunoblot-
ted with an HA antibody to detect Dll3 interaction with N1.
Both Dll1 and Dll3 coimmunoprecipitated with N1 (Fig. 3 F).
To control for postlysis interactions, lysates from Dll1- or Dll3-
expressing cells were mixed with equal amounts of N1 lysate
and were coimmunoprecipitated. Neither Dll3 nor Dll1 immu-
noprecipitated with N1 from mixed lysate controls (unpublished
data). Therefore, in contrast to trans conditions, Dll3 stably
interacts with N1, but the association requires the expression of
both proteins in the same cell (cis conditions).
 
Dll3 promotes primary neurogenesis in 
 
X. laevis 
 
embryos, indicating a block in 
N signaling
 
Our findings that Dll3 does not activate N signaling in cultured
cells are at odds with a previous report in which Dll3 was shown
Figure 3. Dll3 cell autonomously inhibits N signaling. (A) NIH 3T3 cells
cotransfected with N1 or N2 and either HA-tagged Dll1, rat Dll3 (rDll3),
mDll3, or vector along with a CSL reporter cocultured with Dll1, J1, or L
cells. Error bars reflect the SD of the mean from four experiments (*, P  
0.01; **, P   0.001; ***, P   0.0001). (B) Western blot of HA-tagged
Dll1 and Dll3 from NIH 3T3 cells indicates expression in CSL reporter as-
says in A. (C) 293T cells cotransfected with N1 myc and either vector,
Dll1, or Dll3 plasmids and cell surface expression of N1 were analyzed
after biotinylation/SAV pull-down and anti-myc (9E10) Western blotting.
(D) 293T cells transfected with vector or HA-N1 and either vector, Dll1, or
Dll3 plasmids were stained live, and mean fluorescence intensity was de-
termined by FACS. Error bars represent SD. (E) 293T cells cotransfected
with Dll1 or Dll3 and N1 myc or vector plasmids and cell surface expres-
sion of Dll1 or Dll3 were determined by biotinylation/SAV pull-down and
anti-HA antibody (12CA5) Western blotting. (F) Lysates from 293T cells
transfected with N1 and either HA-tagged Dll1, Dll3, or vector were incu-
bated with N1 antibodies and HA antibody Western blot to detect Dll1 or
Dll3 (12CA5; top) or with N1 antibody (93–4; bottom). Middle panel is a
HA Western blot of Dll1 and Dll3 from WCL. 
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to activate N signaling when tested in 
 
X. laevis 
 
embryos (Dun-
woodie et al., 1997). In 
 
X. laevis
 
, the formation of primary neu-
rons can be used as a reliable readout of N signaling. In embryos
in which N signaling is increased, the generation of primary neu-
rons is markedly reduced, whereas the expression of N antago-
nists causes a reciprocal increase in primary neurons (Wettstein
et al., 1997). Because Dll3 was previously reported to inhibit
neurogenesis in this assay, we reexamined its activity in relation
to that of Dll1. As previously demonstrated, injecting 250 pg
Dll1 mRNA at the two-cell stage causes a marked decrease in
the number of cells that express the neuronal marker 
 
 
 
-tubulin at
neural plate stages (Fig. 4, compare A with B; Chitnis et al.,
1995; Dunwoodie et al., 1997). This decrease is indicative of ac-
tivated N signaling (Chitnis et al., 1995) and is similar in nature
to that observed when embryos are injected with NICD,
XDelta1, or mDll4 (Shutter et al., 2000). In contrast, injecting ei-
ther 250 pg or 1 ng mDll3 mRNA not only failed to inhibit neu-
rogenesis but, in some cases, produced an increase in the number
of 
 
 
 
-tubulin–positive neurons (Fig. 4, C and D; and Table I).
Thus, in our hands, Dll3 does not activate N signaling when ec-
topically expressed during neurogenesis but, instead, behaves as
an N inhibitor. We cannot account for the difference between
these results and those obtained with equivalent amounts of
injected Dll3 mRNA from the same Dll3 clone, which was re-
ported previously (Dunwoodie et al., 1997). One possibility is
that a suppression or delay in neuronal differentiation is often an
artifact that occurs in RNA injection experiments. Nonetheless,
our results indicate that Dll3, over a large concentration range,
primarily acts as an inhibitory ligand in the 
 
X. laevis 
 
assay,
which is in line with our findings in mammalian cell culture
assays. Importantly, Dll1 prevents neurogenesis at the same
concentration (250 pg), whereas Dll3 promotes neurogenesis,
highlighting the different activities of these DSL ligands.
 
Dll3 antagonism of N signaling regulates 
neuronal and glial differentiation
 
Both Dll1 and Dll3 are expressed in the developing brain (Dun-
woodie et al., 1997; Campos et al., 2001), where N signaling is
known to regulate the differentiation of progenitors into neu-
rons and glia. We have previously reported that D1Fc inhibits
neurogenesis and promotes gliogenesis in mammalian neural
stem cells (NSCs; Morrison et al., 2000; Ge et al., 2002). To
further demonstrate Dll3 antagonism of N signaling, we trans-
fected cortical NSCs with Dll3 or vector and induced astroglio-
genesis with D1Fc as previously described (Ge et al., 2002). In
this system, Dll3 reduced expression of the astrocyte markers
glial fibrillary acidic protein (GFAP) and S100
 
 
 
, which were
measured by the activation of GFAP and S100
 
 
 
 reporters
(Fig. 5, A and B). Because both GFAP and S100
 
 
 
 regulatory
regions contain functional CSL-binding sites, they are direct
targets of N activation and, thus, serve as readouts of N signal-
ing as well as gliogenesis (Ge et al., 2002; Hermanson et al.,
2002). Dll3 not only suppressed D1Fc-induced N signaling that
was required to drive the transcription of GFAP and S100
 
 
 
, but
it also antagonized signaling that was induced by endogenous
ligands (Fig. 5, A and B; Fc treated). Even in the absence of
D1Fc, NSCs ectopically expressing Dll3 did not express
GFAP, and the number of GFAP-positive cells as well as the
level of GFAP expression was decreased by Dll3 transfection
(Fig. 5, C and D) or infection with Dll3 adenovirus (Fig. 5 E).
In contrast to Dll1 that is known to block neurogenesis, Dll3
promoted neurogenesis of early (neurogenic) stage NSCs, as
measured by increased NeuroD promoter activity (Fig. 5 F) and
expression of the neuronal-specific marker 
 
 
 
-tubulin (TuJ1;
Fig. 5 G). Because N signaling prevents neurogenesis (Lewis,
1996), neural induction in the presence of Dll3 in cortical pro-
genitors is in agreement with Dll3 functioning as a signaling
antagonist of N in both our cell coculture (Fig. 3 A) and 
 
X. laevis
 
injection assays (Fig. 4, C and D). Together, our findings sug-
gest that Dll3 promotes neurogenesis and inhibits gliogenesis
through antagonizing N and uncover a biological role for Dll3
as a negative regulator of cell fate decisions that are influenced
by N signaling.
 
LFng and Dll3 function cell autonomously 
to modulate N signaling levels
 
Although the loss of either Dll1 or Dll3 leads to defects in
somitogenesis, Dll1 mutants display a complete loss of somite
polarity markers, which is similar to RBP-J knockout mice,
highlighting that Dll1 and RBP-J are core components of the N
pathway (for review see Giudicelli and Lewis, 2004). In contrast,
Figure 4. Injection of mDll3 mRNA promotes neurogenesis in X. laevis.
Representatives of embryos injected with either synthetic lacZ mRNA
alone (A) or in combination with 250 pg Dll1 mRNA (B), 250 pg mDll3
mRNA (C), or 1,000 pg mDll3 mRNA (D) and stained for X-gal (light blue)
and  -tubulin (purple) expression. Arrows indicate injection site.
 
Table I. 
 
Quantitation of 
 
 
 
-tubulin–positive neurons in D1- or mDll3-
injected embryos
Injected mRNA
Increase in
neurons
Reduction or
complete loss
of neurons No change
Total embryos
scored
 
Control
 
 
 
(
 
 
 
-galactosidase) 4 3 48 55
Dll1 (250 pg) 1 23 9 33
Dll3 (250 pg) 15 0 5 20
Dll3 (1,000 pg) 15 3 7 25
 
Embryos were injected and processed (Chitnis et al., 1995) to determine the
relative amounts of 
 
 
 
-tubulin that were scored either as an increase, reduction,
or complete loss of neurons or as no change. 
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losses in Dll3 produce only disorganization in somite patterning,
which is a phenotype that is strikingly similar to gains or losses
in the N modulator LFng. These findings suggest that although
Dll1 is an activating ligand that is absolutely required for N sig-
naling, Dll3 and LFng may serve to regulate levels of N signal-
ing during somitogenesis. To explore the relationship between
LFng and Dll3 in modulating N signaling that is induced by
other DSL ligands, we used the CSL reporter assay. When cells
transiently expressing N1, CSL reporter, and either Dll3 or vec-
tor as well as low (100 ng) or high (500 ng) amounts of LFng
DNA were cocultured with Dll1 cells, LFng appeared to coun-
teract the inhibitory effects of Dll3 in a dose-dependent manner
(Fig. 6 A). Specifically, increases in transfected LFng increased
signaling even in the presence of Dll3, suggesting a dynamic in-
terplay between LFng and Dll3 in modulating the level of N1
signaling. Conversely, LFng enhancement of Dll1-induced N
signaling was suppressed by Dll3 in a dose-dependent manner
(Fig. 6 B). Together, these experiments illustrate the dynamic
nature of Dll1-induced N signaling in response to Dll3 and sug-
gest that, like LFng, Dll3 also modulates N signaling.
Fringe proteins have been reported to override the cis-
inhibitory effects of other DSL ligands in flies and chicks
(Hukriede et al., 1997; de Celis and Bray, 2000; Sakamoto et
al., 2002). It has been proposed that LFng modification of N
and/or DSL ligand disrupts cis-inhibitory complexes to allow
N activation by adjacent ligand cells. In this regard, two Dll3
EGF-like repeats have broad O-fucosylation consensus se-
quences, which is a prerequisite for LFng glycosylation (Panin
et al., 2002). To determine whether LFng glycosylation of N1
or Dll3 disrupts interactions between Dll3 and N1, coimmuno-
precipitation of N1 with Dll3 was measured in the presence of
LFng. Irrespective of LFng coexpression, N1 coimmunopre-
cipitated with Dll3 (Fig. 6 C), and, conversely, Dll3 coimmu-
noprecipitated with N1 (not depicted), indicating that LFng
does not alter cis interactions between Dll3 and N1. Even in-
creasing amounts of LFng did not disrupt Dll3–N1 interactions
(unpublished data).
Because LFng did not prevent interactions between Dll3
and N1, it seemed that LFng enhancement of Dll1 signaling in
combination with Dll3-inhibitory effects could account for
LFng reversing Dll3 cis inhibition. LFng both potentiates Dll1-
induced N1 signaling and inhibits signaling by J1 (Hicks et al.,
2000; Yang et al., 2004). Therefore, we reasoned that if LFng
exclusively modulates trans signaling and has no effect on
Dll3–N1 cis interactions, the coexpression of Dll3 and LFng
with N1 should result in a greater inhibition of J1-induced N
signaling than with either modulator alone. Conversely, if
LFng functions directly to prevent cis inhibition by Dll3, then
Dll3 coexpression should not further inhibit signaling by J1.
The coexpression of either LFng or Dll3 suppressed J1-induced
N1 signaling, whereas the coexpression of both LFng and Dll3
produced a stronger block in signaling (Fig. 6 D). This indi-
cates that LFng does not disrupt Dll3 cis inhibition but rather
functions to modulate the productivity of N signaling that was
induced by trans ligand. LFng coexpression with Dll3 further
inhibited N1 signaling that was induced by J1, yet reversed the
Dll3 inhibition of signaling in response to Dll1. This suggests
that, together, LFng and Dll3 could finely tune the levels of N
signaling that are induced by different DSL ligands.
 
Discussion
 
In contrast to other DSL ligands, the reported activating ligand
Dll3 (Dunwoodie et al., 1997) did not bind or activate N when
tested in a number of different assays. Despite the inability of
Dll3 to induce signaling from any of the known N receptors,
we find that Dll3 is a potent antagonist of ligand-induced N
signaling when coexpressed with N. Indicative and supportive
of Dll3 antagonism of N signaling, we show that Dll3 promotes
primary neurogenesis in 
 
X. laevis 
 
embryos and enhances neu-
ronal differentiation of mouse cortical neural progenitors in
vitro, whereas glial differentiation is reduced. In combination
with LFng, which is a well-known modulator of ligand-induced
N signaling, Dll3 regulates the level of signaling, suggesting
that it may contribute to the dynamic changes in N signaling
that are required in development.
 
Dll3 is a highly divergent DSL family 
member
 
Dll3 has 36, 41, 31, and 29% overall amino acid homology to
mDll1, 
 
X. laevis 
 
Delta2, mDll4, and 
 
Drosophila melanogaster
Figure 5. Dll3 suppresses D1Fc-induced astrocytic differentiation. Embry-
onic day 11.5 mouse cortical NSCs cotransfected with reporters for GFAP
(A) or S100  (B) and either vector or Dll3 were treated with control Fc or
D1Fc to induce astrogliogenesis. (C) NSCs cotransfected with GFP and ei-
ther vector or Dll3 were cultured with D1Fc for 4 d and stained for GFAP.
(D) Quantitation of transfected cells expressing GFAP from six indepen-
dent experiments. (E) GFAP expression in NSCs infected with control (lane
1) or Dll3 adenovirus (lane 2) as determined by Western blotting. (F) Neu-
rogenic stage mouse cortical NSCs cotransfected with NeuroD promoter
luciferase construct and vector or Dll3. Promoter activation is plotted as
relative luciferase units for six experiments. P   0.05. *, significant differ-
ences between Dll3 and vector; **, significant increase between Fc and
D1Fc. Error bars represent SD. AU, arbitrary units. (G) Tubulin (TuJ1) ex-
pression in NSCs infected with control (lane 1) or Dll3 adenovirus (lane 2)
as determined by Western blotting. 
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Delta, respectively, identifying Dll3 as the most divergent
DSL member (Dunwoodie et al., 1997). Dll3 is also the short-
est of the mammalian Dll ligands, with only six EGF-like re-
peats compared with eight repeats identified for Dll1 and Dll4.
A comparison of the Dll3 DSL domain with mDll1, mDll4, 
 
X.
laevis 
 
Dll2, 
 
D. melanogaster 
 
Delta, and zebrafish DeltaA-D
highlights its divergence (Fig. 2 D). Interestingly, although a
large number of Delta homologues have been identified in ze-
brafish, none appear to have the degenerate DSL domain that
is characteristic of Dll3. The DSL domain is thought to be im-
portant in receptor binding and activation (Henderson et al.,
1997; Shimizu et al., 1999). However, a soluble form of J1
containing only the NT-DSL fused to Fc binds poorly to N,
and the addition of the first two J1 EGF-like repeats is re-
quired to enhance binding (Shimizu et al., 1999). Therefore, it
was surprising that replacement of the Dll3 NT-DSL se-
quences with those of Dll1 in D1
 
NT
 
D3Fc did not promote
binding to N1. In fact, if one assumes that Dll1 NT-DSL facil-
itates interactions, it seems that Dll3 EGF-like repeats antago-
nize Dll1 NT-DSL binding to N, suggesting that additional
differences in Dll3 perturb Dll3–N interactions. In support of
this idea, the replacement of NT-DSL sequences in full-length
Dll3 with those of Dll1 did not promote N1Fc binding to
D1
 
NT
 
D3 cells. These findings suggest that Dll3 EGF-like re-
peats do not function as reported for J1 EGF-like repeats,
identifying additional differences between Dll3 and other DSL
ligands. Interestingly, the second Dll3 EGF-like repeat is in-
complete, and missense mutations map to this and other re-
peats in spondylocostal dysostosis patients (Bulman et al.,
2000; Turnpenny et al., 2003), suggesting that these repeats
are important for Dll3 function. An analysis of different Dll1–
Dll3 chimeric proteins will be required to further investigate
the structural differences between Dll1 and Dll3.
In addition to differences in Dll3 extracellular sequences,
the intracellular domain is significantly smaller than that of
Dll1 and other DSL family members (Dunwoodie et al., 1997).
The Delta intracellular domain is required for the activation of
N signaling, perhaps reflecting its role in endocytosis that is
regulated through ubiquitination (for review see Le Borgne et
al., 2005). Although the exact function of Delta ubiquitination
in N signaling is not well understood, it is interesting to note
that although the Dll1 intracellular domain contains 17 lysine
residues, which are potential sites for ubiquitination, there are
no lysines in the Dll3 intracellular domain. Given the impor-
tance of ubiquitination in Delta-induced N signaling, the lack
of lysines in Dll3 is consistent with our findings that Dll3 is un-
able to activate N signaling.
Finally, the COOH terminus of Dll3 lacks a PDZ-binding
motif that is present in other DSL proteins and directs different
cellular responses through interactions with PDZ domain–
containing proteins (Ascano et al., 2003; Pfister et al., 2003;
Six et al., 2003; Wright et al., 2004), identifying additional
functional differences for Dll3. Thus, in addition to extracellu-
lar changes that prevent N binding in trans, Dll3 appears to
have undergone other alterations that do not promote signaling.
Because our data suggest that Dll3 functions to inhibit rather
than activate N signaling, associations of Dll3 with N pathway
genes likely reflect a role for Dll3 as a signaling antagonist
rather than as an activating ligand.
 
Dll3 as a modulator of cellular 
differentiation induced by N signaling
 
Dll1 and Dll3 have overlapping as well as distinct expression
patterns in the developing cortex and spinal cord (Dunwoodie
et al., 1997; Kusumi et al., 1998; Campos et al., 2001; Sparrow
et al., 2002). Specifically, Dll1 is expressed within the ventric-
ular zone, whereas Dll3 is located more laterally in a popula-
tion of cells that is thought to be fated for terminal neuronal
differentiation. It has been proposed that Dll1 ventricular cells
express Dll3 after migrating away from the ventricular zone,
and that this sequential expression of Dll1 and Dll3 is linked to
progression toward a neuronal fate. Consistent with this idea,
we find that ectopic expression of Dll3 in either 
 
X. laevis 
 
oocytes
or neural progenitors blocks N signaling and promotes terminal
Figure 6. LFng and Dll3 dynamically modulate N signaling. (A)
NIH 3T3 cells cotransfected with N1 and CSL reporter as well as
vector or Dll3 with increasing amounts of LFng or control DNA were
cocultured with L or Dll1 cells and assayed for luciferase activity. (B)
NIH 3T3 cells cotransfected with N1 and CSL reporter as well as
control or LFng, and either vector or increasing amounts of Dll3 DNA
were cocultured with L or Dll1 cells. P   0.01. *, a significant differ-
ence between vector and Dll3 (low); **, a significant difference be-
tween Dll3 (low) and Dll3 (high). n = 5. (C) Lysates from 293T cells
cotransfected with N1 myc, HA-tagged Dll3, and LFng or control
DNA incubated with anti-HA antibody to capture Dll3 immunopre-
cipitates, which were identified by anti-myc Western blotting to de-
tect N1 (right). Lysate from N1 cells was mixed with equal amounts
of D3 lysate and was analyzed alongside other samples (Mix Lys).
WCLs were analyzed by anti-myc (top left) and anti-HA Western
blotting (bottom left). (D) Parental L or J1 cells cocultured with NIH
3T3 cells that were transfected with N1, CSL reporter, vector, or Dll3
and control or LFng. (*, P   0.005; **, P   0.001; n = 7). Error
bars represent SD.JCB • VOLUME 170 • NUMBER 6 • 2005 990
neuronal differentiation. However, pudgy and Dll3 knockout
mice display only subtle neuroepithelial defects in the lateral
ventricles with a low penetrance of  50%, suggesting that if
Dll3 does regulate neural differentiation, its effects must be
transient. Nonetheless, our findings that Dll3 regulates neu-
ronal cell fate are consistent with a role for Dll3 as a modulator
of N signaling rather than as a core component of the pathway
and support a role for Dll3 in altering progenitor cell fate
through attenuating N signaling.
LFng and Dll3 function together to cell 
autonomously modulate N signaling
Loss of Dll3 causes severe defects in somite patterning and ax-
ial elongation, identifying a role for Dll3 in somitogenesis
(Kusumi et al., 2004). Similar somite defects have been ob-
served for both gains and losses in LFng (Serth et al., 2003),
suggesting that Dll3 may also modulate the levels of N signal-
ing during somite development, as proposed for LFng. Based
on the published roles for fringe in modulation of N–ligand in-
teractions, LFng and Dll3 were tested for their ability to coordi-
nately regulate N signaling. We found that LFng modification
of N did not enable Dll3 to function in trans as an activating
ligand. Instead, LFng enhanced N signaling to override Dll3
cis-inhibitory effects on activation by Dll1. The effects of LFng
did not prevent interactions between Dll3 and N1 even though
both Dll3 and N1 contain multiple potential sites for LFng gly-
cosylation. Our findings that the coexpression of LFng and
Dll3 with N1 additively blocked J1-induced CSL activation
suggest that LFng regulates trans ligand–N interactions,
whereas Dll3 inhibits N activation through cis interactions.
Altogether, our results suggest that Dll3 and LFng coordinately
function in a cell-autonomous manner to modulate ligand-
induced N signaling.
Spatial and temporal changes in N signaling within the
PSM appear to be critical for proper segmental patterning (for
review see Giudicelli and Lewis, 2004), and it has been pro-
posed that N signaling in the PSM must fall below a certain
threshold during each segmental cycle to ensure proper somite
patterning (Serth et al., 2003). Given our observations that Dll3
and LFng function together to dynamically regulate ligand-
induced N signaling, it is tempting to speculate that Dll3 may
participate in the negative feedback loops that regulate cyclic
activation of N signaling during somitogenesis.
Dll3 is an inhibitor of N signaling
We have found that Dll3 is not an activating ligand for N but
rather functions to cell autonomously inhibit signaling. In sup-
port of Dll3 as an N antagonist, findings in mice have also pro-
posed that Dll3 counteracts the activity of Dll1 in regulating N
signaling during somite patterning (Takahashi et al., 2003).
Consistent with Dll3 functioning as a negative regulator, the ex-
pression of an N target gene, N-regulated ankyrin repeat protein
(NRARP), is extinguished in nascent somites in mice lacking
either N1 or Dll1 but is increased in pudgy mice (Krebs et al.,
2001). Perhaps, Dll1-induced N signaling activates NRARP
expression, whereas Dll3 antagonizes this signaling, and, thus,
a loss of Dll3 leads to an increase in N signaling and a conse-
quential increase in NRARP expression. In contrast, expression
of the N target gene Hes5 is either absent or reduced in the PSM
of Dll3 mutant embryos (Dunwoodie et al., 2002), which is sup-
portive of Dll3 as an activator of N signaling. However, it is im-
portant to note that Dll1 mutant embryos that are defective in N
signaling show a reduction or loss of Hes5 in both the PSM and
neural tube, whereas Dll3 mutants maintain strong Hes5 expres-
sion in the neural tube (Barrantes et al., 1999; Dunwoodie et al.,
2002). Because somitogenesis, unlike the developing nervous
system, requires cyclic N signaling, losses in Dll3 may ad-
versely affect negative feedback loops that are required to main-
tain proper levels of N signaling in the PSM in order to affect
Hes5 expression. Nonetheless, Dll3 and Dll1 mutant somite
phenotypes are clearly different, suggesting that Dll3 and Dll1
have distinct functions in regulating N signaling during somito-
genesis (Kusumi et al., 2004). Our findings support this idea,
and we suggest that the different activities identified in this
study for Dll1 and Dll3 may account for the distinct mutant phe-
notypes. Finally, our finding that Dll3 has diverged to function
solely as an inhibitor of N signaling that is induced by other
DSL ligands is reminiscent of reports for other signaling antag-
onists that are structurally related to their activating ligands but
function to inhibit rather than activate signaling (Vinos and
Freeman, 2000; Daluiski et al., 2001).
Materials and methods
Cell lines and mammalian expression constructs
Parental cell lines were obtained from the American Type Culture Collec-
tion and were propagated as suggested. Stable C2C12 cell lines express-
ing N1 and L cell lines expressed Dll1 or J1 have been described previ-
ously (Lindsell et al., 1995; Hicks et al., 2000). Stable Dll3-expressing
cells were generated by using hypoxanthine and thymine selection as pre-
viously described for J1-expressing L cells (Lindsell et al., 1995).
rDll3 was isolated from an embryonic day 13 rat brain cDNA library
(GenBank/EMBL/DDBJ accession no. AF084576) based on homology to
mDll3 (cDNA obtained from S. Dunwoodie, University of New South
Wales, Sydney, Australia; Dunwoodie et al., 1997) and was tagged with
triple tandem repeat of the influenza virus HA epitope. HA-tagged rDll3
and the previously described Dll1 were subcloned into pCS2 expression
vectors (Turner and Weintraub, 1994). Dll3Fc was generated by fusing
the extracellular domain of Dll3 (1–1476 bp) to Fc and subcloning into
the pcDNA3 expression vector (Invitrogen). D1
NTD3Fc and D1
NTD3 were
constructed by replacing the first 651 bp of Dll3Fc or HA-tagged Dll3, re-
spectively, with the NH2 terminus and DSL domain of Dll1 (1–725 bp).
N1 myc replaced the COOH-terminal 436 amino acids of full-length rat
N1 with six myc epitopes in the pCS2 mt vector (Yang et al., 2004).
NH2-terminal HA-tagged N1 (HA-N1) was generated by inserting the tri-
ple HA epitope immediately downstream of the signal peptide by using a
PCR overlap strategy and subcloning into pBOS.
Biotinylation, immunoprecipitation, and Western blot analysis
Cell surface proteins were labeled with biotin and isolated as previously
described (Bush et al., 2001). In brief, 293T cells were cotransfected with
0.5 g N1 myc and 0.5 g of either Dll3, Dll1, or vector per 60-mm dish us-
ing a standard Hepes-based calcium phosphate precipitation method. After
48 h, the cells were washed with cold PBS and were incubated in PBS con-
taining 0.5 mg/ml Sulfo-NHS-Biotin (Pierce Chemical Co.) for 1 h at 4 C.
Cells were washed with glycine buffer (20 mM Tris, pH 7.4, 300 mM
NaCl, 0.1% BSA, and 100 mM glycine) and were incubated in glycine
buffer for another 15 min. Cells were lysed with radioimmunoprecipitation
assay buffer (50 mM Tris, pH 7.5, 150 mM NaCl, 1% NP-40, 0.5% deoxy-
cholate, and 0.1% SDS) containing protease inhibitors (1 mM PMSF, 10
 g/ml leupeptin, and 10  g/ml aprotinin). WCLs were incubated with
SAV-immobilized beads (Pierce Chemical Co.) at 4 C for 10–12 h.
Coimmunoprecipitation experiments (for Fig. 3 F) also used 293T
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cold PBS but lysed in Triton X-100 buffer (50 mM Hepes, pH 7.5, 150 mM
NaCl, 1.5 mM MgCl2, 1 mM EGTA, 10% glycerol, and 1% Triton X-100).
WCLs were incubated on ice for 1 h with a mixture of anti-N1 intracellu-
lar domain pAbs (PCR12 and 93–4) at 1:200 each. For pull-downs be-
tween LFng modified N1 and Dll3 (Fig. 6 C), the immunoprecipitation
protocols were based on methods published by Sakamoto et al. (2002).
In brief, 293T cells were plated at a density of 1.5   10
6 cells per 60-
mm dish and were transfected with LipofectAMINE (Invitrogen) according
to the manufacturer’s instructions using 0.3  g N1, Dll3, or vector and
1  g of secreted alkaline phosphatase or LFng DNA. Cells were lysed in
1% Triton X-100 lysis buffer (100 mM Tris-Cl, pH 7.5, 150 mM NaCl, 1
mM CaCl2, and 1% Triton X-100; Sakamoto et al., 2002). Lysate was in-
cubated with a mAb anti-HA (3F10; Roche Biosciences) and rabbit anti–
rat Ig for 30 min–1 h on ice. Immunoprecipitates were collected on pro-
tein A agarose beads (Invitrogen). Specific proteins were identified after
SDS/PAGE, transferred to NitroBind membrane (Osmonics), probed with
93–4 (1:1,000), 12CA5 (1:2,000), or 9E10 (1:1,000; Santa Cruz Bio-
technology, Inc.) antibodies, and were detected using ECL Plus Western
blotting detection system (GE Healthcare) and a scanner (Typhoon 9410;
GE Healthcare).
CSL gene reporter assay
CSL reporter was provided by D. Hayward (Johns Hopkins School of Med-
icine, Baltimore, MD). NIH 3T3 cells were cotransfected at 70% conflu-
ence according to the manufacturer’s suggested protocols for Lipo-
fectAMINE (Invitrogen) with 0.25  g CSL reporter, 0.005  g Renilla
luciferase (RLCMV), 0.1 g N DNA, and 0.1  g vector or cis ligand DNA.
24 h posttransfection, cells were cocultured with ligand-expressing L cell
lines or the parental L cell line control, and lysates were collected 48 h
posttransfection and assayed using the Dual Luciferase Reagent system
(Promega).
Cell surface labeling and ligand-binding assays
HEK 293T cells were calcium phosphate transfected with vector or HA-N1
and either vector, Dll1, or Dll3 plasmids. To detect N1 cell surface expres-
sion, cells were also transfected with pHcRed (BD Biosciences and CLON-
TECH Laboratories, Inc.), and 48 h posttransfection, cells were stained live
with an AlexaFluor488-conjugated HA mouse monoclonal (16B12; Mo-
lecular Probes). The pHcRed-expressing cells emitting fluorescence at 660
nm were assayed for mean fluorescence intensity at 530 nm to detect the
AlexaFluor488 signal using FACSCalibur (Becton Dickinson) as previ-
ously described (Hicks et al., 2002; Yang et al., 2004). For binding stud-
ies, D1Fc, Dll3Fc, D1
NTD3Fc, or Fc conditioned medium was generated as
previously described (Hicks et al., 2000, 2002) and was diluted to similar
levels of expression. N1Fc containing the first 12 EGF-like repeats of rat
N1 fused to Fc was purchased from R&D Systems. 293T cells were plated
in 24-well plates and transfected with Transfast (Promega) using 60 ng of
either vector or N1 and Dll1, Dll3, or D1
NTDll3 DNA per well according
to the manufacturer’s recommended protocols. 48 h posttransfection, cells
were incubated for 45 min at 37 C in blocking media (DME containing
10% goat serum and 1% BSA). To determine the level of binding, Fc fu-
sion proteins were preclustered with FITC-conjugated goat anti–human Fc
antibody (1:200; Jackson ImmunoResearch Laboratories) at 4 C for 1 h.
Serial dilutions of the clustered ligand (Fig. 2, A and B) or 1  g/ml N1Fc
were added to cells for 40–60 min at 37 C. After binding, the cells were
resuspended and washed in wash buffer (PBS, 0.2% BSA, and 0.1%
NaN3) and were analyzed by FACScan (BD Biosciences).
X. laevis embryo injections
Single blastomeres of two- or four-cell stage X. laevis embryos were in-
jected with 50 pg synthetic lacZ mRNA alone or in combination with Dll1
or Dll3 mRNA. Embryos were stained for X-gal and  -tubulin expression at
the neural plate stage as previously described (Chitnis et al., 1995; Wett-
stein et al., 1997). X. laevis embryos were imaged at RT in ethanol using
a photomicroscope (Wild M420; Leica) with an Apozoom lens at 32 
and a camera (model DP11; Olympus). Images were acquired using
Olympus software and were processed using Adobe Photoshop to adjust
brightness and contrast, which was applied to the entire image.
Mouse cortical NSC culture and differentiation assays
NSCs were isolated and cultured from embryonic day 11.5 BALB/c
mouse cortex as previously described (Ge et al., 2002). Progenitors were
cultured in concentrated and clustered Fc or D1Fc conditioned medium as
previously described (Morrison et al., 2000). For reporter assays, NSCs
were plated onto polyornithine/fibronectin-coated 96-well plates at a den-
sity of 2–4   10
6 cells/plate. Using Fugene 6 transfection method (Roche
Biosciences), cells were cotransfected with vector or Dll3 as well as with
promoters of interest driving the firefly luciferase (pGL3) and a constitu-
tively active thymidine kinase promoter driving Renilla luciferase (TK-pRL)
as internal controls for transfection efficiency. 24 h posttransfection, cells
were lysed, and promoter activities were assayed using the Promega Dual
Luciferase Assay kit. NSC cultures were infected with control or Dll3 ade-
novirus as previously described (Sun et al., 2001). GFAP or TuJ1 expres-
sion was determined by immunoblotting using standard protocols (Ge et
al., 2002). NSC cultures were stained with Cy3- and Cy2-conjugated an-
tibodies and were imaged at RT using a microscope (model BX51; Olym-
pus) with a UplanApo 20 /0.7 objective (Olympus) and a camera
(model IKH027779; Olympus). Images were acquired using Magna FIRE
software (Optronics) and were processed using Adobe Photoshop for
cropping, resizing, and merging.
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